(Q59571635)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23395639%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

title

Sunitinib does not accelerate tumor growth in patients with metastatic renal cell carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23395639%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

metastatic renal cell carcinoma

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23395639%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Robert Motzer

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23395639%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

5

Susan E Bates

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23395639%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

6

A Tito Fojo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23395639%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

author name string

Krastan B Blagoev

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23395639%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

Wilfred D Stein

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23395639%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

publication date

7 February 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23395639%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23395639%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23395639%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23395639%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

page(s)

277-281

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23395639%20AND%20SRC:MED&resulttype=core&format=json

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

23 February 2020

cites work

1 reference

12 December 2020

Basic and therapeutic aspects of angiogenesis

1 reference

12 December 2020

Hallmarks of Cancer: The Next Generation

1 reference

12 December 2020

Bevacizumab reduces the growth rate constants of renal carcinomas: a novel algorithm suggests early discontinuation of bevacizumab resulted in a lack of survival advantage

1 reference

12 December 2020

Vascular endothelial growth factor

1 reference

12 December 2020

Isolation of a tumor factor responsible for angiogenesis

1 reference

12 December 2020

Vascular endothelial growth factor signaling pathways: therapeutic perspective

1 reference

12 December 2020

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

1 reference

12 December 2020

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

12 December 2020

Sunitinib: a multitargeted receptor tyrosine kinase inhibitor in the era of molecular cancer therapies

1 reference

12 December 2020

Tumor angiogenesis: therapeutic implications

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Analyzing the pivotal trial that compared sunitinib and IFN-α in renal cell carcinoma, using a method that assesses tumor regression and growth.

1 reference

12 December 2020

1 reference

12 December 2020

Overall survival and updated results for sunitinib compared with interferon alfa in patients with metastatic renal cell carcinoma

1 reference

12 December 2020

10.1016/J.CELREP.2013.01.015

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23395639%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23395639%20AND%20SRC:MED&resulttype=core&format=json

23 February 2020

PubMed publication ID

23395639

1 reference